logo
Asia stocks slip amid US tariff confusion, oil skids

Asia stocks slip amid US tariff confusion, oil skids

The Star2 days ago
SYDNEY: Stock markets slipped in Asia amid much confusion as U.S. officials flagged a delay on tariffs but failed to provide any detail or paperwork on the change, while oil prices slid as OPEC+ opened the supply spigots more than expected.
The United States is close to finalising several trade agreements in the coming days and will notify other countries of higher tariff rates by July 9, President Donald Trump said on Sunday, with the higher rates to take effect on August 1.
"President Trump's going to be sending letters to some of our trading partners saying that if you don't move things along, then on August 1 you will boomerang back to your April 2 tariff level," U.S. Treasury Secretary Scott Bessent told CNN.
Trump in April announced a 10% base tariff rate on most countries and higher "reciprocal" rates ranging up to 50%, with an original deadline of this Wednesday.
However, Trump also said levies could range in value from "maybe 60% or 70% tariffs to 10% and 20%", further clouding the picture.
With very few actual trade deals done, analysts had suspected the date would be pushed out, though it was still not clear if the new deadline applied to all trading partners or just some.
"This renewed escalation in trade tensions comes at a time when major trade partners, including the EU, India and Japan, are believed to be at crucial stages of bilateral negotiations," analysts at ANZ said in a note.
"If reciprocal tariffs are implemented in their original form or even expanded, we believe it will intensify downside risks to U.S. growth and increase upside risks to inflation."
Investors have grown somewhat used to the uncertainty surrounding U.S. trade policy and the initial market reaction was cautious. S&P 500 futures and Nasdaq futures both eased 0.3%.
Japan's Nikkei lost 0.3%, while South Korean stocks fell 0.7%. MSCI's broadest index of Asia-Pacific shares outside Japan eased 0.1%.
DOLLAR DOLDRUMS
Safe-haven bonds were better bid, with 10-year Treasury yields down almost 2 basis points at 4.326%.
Major currencies were little changed as the dollar index continued to languish near four-year lows at 96.913. The euro held at $1.1787, just off last week's top of $1.1830, while the dollar dipped to 144.38 yen.
The dollar has been undermined by investor concerns about Trump's often chaotic tariff policy and what that might do to economic growth and inflation. The same worries have kept the Federal Reserve from cutting rates and minutes of its last meeting should offer more colour on when the majority of members might resume easing.
It is a relatively quiet week for Fed speakers with only two district presidents on the docket, while economic data is also sparse. The Reserve Bank of Australia is widely expected to cut its rates by a quarter point to 3.60% at a meeting on Tuesday, the third easing this cycle, and markets imply an eventual destination for rates of 2.85% or 3.10%.
New Zealand's central bank meets on Wednesday and is likely to hold rates at 3.25%, having already slashed by 225 basis points over the past year.
In commodity markets, gold slipped 0.3% to $3,324 an ounce , though it did gain almost 2% last week as the dollar fell.
Oil prices slid anew after the Organization of the Petroleum Exporting Countries and their allies, a group known as OPEC+, agreed on Saturday to raise production by a larger-than-expected 548,000 barrels per day in August.
The group also warned that it could hike by a similar amount in September, leaving analysts with the impression it was trying to squeeze lower margin producers and particularly those pulling oil from U.S. shale.
Brent dropped 52 cents to $67.78 a barrel, while U.S. crude fell $1.01 to $65.99 per barrel. - Reuters
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Malaysian Reserve

timean hour ago

  • Malaysian Reserve

Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

CRANFORD, N.J. , July 8, 2025 /PRNewswire/ — Citius Pharmaceuticals, Inc. ('Citius Pharma' or the 'Company') (Nasdaq: CTXR) today announced that it has received formal notification from The Nasdaq Stock Market LLC ('Nasdaq') indicating that for 10 consecutive trading days, from June 20, 2025 to July 3, 2025, the closing bid price of the Company's common stock was at $1.00 per share or greater, and accordingly, the Company regained compliance with Nasdaq Listing Rule 5550(a)(2). The previously scheduled Nasdaq Hearing Panel has been cancelled. Nasdaq informed the Company that Citius Pharma's securities will continue to be listed and traded on the Nasdaq Stock Market. 'We are pleased to have regained compliance with Nasdaq's minimum bid price requirement,' said Leonard Mazur, Chairman and CEO of Citius Pharmaceuticals. 'This reflects our continued focus on bringing critical care products to patients and creating long-term value for our shareholders.' About Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. In August 2024, the FDA approved LYMPHIR, a targeted immunotherapy for an initial indication in the treatment of cutaneous T-cell lymphoma. Citius Pharma's late-stage pipeline also includes Mino-Lok®, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. A Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido were completed in 2023. Mino-Lok met primary and secondary endpoints of its Phase 3 Trial. Citius is actively engaged with the FDA to outline next steps for both programs. Citius Pharmaceuticals owns 92% of Citius Oncology. For more information, please visit Forward-Looking Statements This press release may contain 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting Citius Pharma or Citius Oncology. You can identify these statements by the fact that they use words such as 'will,' 'anticipate,' 'estimate,' 'expect,' 'plan,' 'should,' and 'may' and other words and terms of similar meaning or use of future dates. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated, and, unless noted otherwise, that apply to Citius Pharma and Citius Oncology, are: our ability to maintain compliance with Nasdaq's continued listing standards; our ability to commercialize LYMPHIR and any of our other product candidates that may be approved by the FDA; our ability to use the latest technology to support our commercialization efforts; our need for substantial additional funds; our ability to successfully implement and maintain distribution agreements with current or other future distribution partners; potential disruptions or performance issues involving third-party logistics providers; the estimated markets for our product candidates and the acceptance thereof by any market; the ability of our product candidates to impact the quality of life of our target patient populations; risks relating to the results of research and development activities, including those from our existing and any new pipeline assets; our dependence on third-party suppliers; our ability to procure cGMP commercial-scale supply; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; the early stage of products under development; market and other conditions; risks related to our growth strategy; patent and intellectual property matters; our ability to identify, acquire, close and integrate product candidates and companies successfully and on a timely basis; government regulation; competition; as well as other risks described in our SEC filings. These risks have been and may be further impacted by any future public health risks. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding our business are described in detail in our Securities and Exchange Commission ('SEC') filings which are available on the SEC's website at Investor Contact:Ilanit AllenVP, Corporate Communications & Investor RelationsCitius Pharmaceuticals, ext. 113 Media Contact:Greg SalsburgSTiR-communicationsGreg@ ext. 113

Trump Says New Tariff Deadline Not 100 Percent Firm
Trump Says New Tariff Deadline Not 100 Percent Firm

Malaysia Sun

timean hour ago

  • Malaysia Sun

Trump Says New Tariff Deadline Not 100 Percent Firm

Trump sent letters to trading partners including key US allies Japan and South Korea, announcing that duties he had suspended in April would snap back even more steeply in three weeks, AFP reported. Tokyo and Seoul would be hit with 25 percent tariffs on their goods, he wrote. Countries including Indonesia, Bangladesh, Thailand, South Africa and Malaysia were slapped with duties ranging from 25 percent to 40 percent. But in a move that will cause fresh uncertainty in a global economy already unsettled by his tariffs, the 79-year-old once again left the countries room to negotiate a deal. I would say firm, but not 100 percent firm, Trump told reporters at a dinner with visiting Israeli regime prime minister Benjamin Netanyahu when asked if August 1 deadline was firm. Pressed on whether the letters were his final offer, Trump replied: I would say final but if they call with a different offer, and I like it, then well do it. The US president had unveiled sweeping tariffs on imports on what he called Liberation Day on April 2, including a baseline 10 percent tariff on all countries. But he quickly suspended all tariffs above 10 percent for 90 days following turmoil in the markets. They were due to kick back in on Wednesday and Trump sent the letters in advance of that deadline. Trumps near-identically worded letters to Japanese and South Korean leaders said he would impose 25 percent tariffs as their trading relationships with Washington were unfortunately, far from Reciprocal. He warned of further escalation if there was retaliation against the levies. But Trump on Monday also signed an order formally extending the Wednesday deadline, postponing it to August 1. The new August date effectively marks a further delay and Trumps latest comments threaten to compound the uncertainty over when the deadline really is. According to letters posted to Trumps Truth Social platform, products from Indonesia will face a 32 percent tariff, while the level for Bangladesh is 35 percent and Thailand, 36 percent. Most countries receiving letters so far had duties similar or unchanged from rates threatened in April, although some like Laos and Cambodia saw notably lower levels. The Trump administration is under pressure to show results after promising 90 deals in 90 days. So far only two firm deals have emerged, with Britain and Vietnam, plus an agreement to dial back super-high tit-for-tat tariffs with China. Japans Prime Minister Shigeru Ishiba said at a cabinet meeting Monday that the announcement of the 25 percent tariffs is genuinely regrettable, local media reported. South Koreas National Security Adviser Wi Sung-lac meanwhile met with his US counterpart Marco Rubio in Washington, expressing hope that a bilateral summit could soon be held to achieve mutually beneficial outcomes across key pending issues. Asked why Trump opted to start with Japan and South Korea, White House Press Secretary Karoline Leavitt said: Its the presidents prerogative, and those are the countries he chose. Thailands acting Prime Minister Phumtham Wechayachai said Tuesday he wanted a better deal than the 36 percent tariff Trump threatened to impose, adding: The most important thing is that we maintain good relations with the US. Malaysia said it was committed to continuing engagement with the US toward a balanced, mutually beneficial, and comprehensive trade agreement, its trade ministry said in a statement, after Washington imposed a 25 percent tariff on the Southeast Asian nation. US Treasury Secretary Scott Bessent said Monday that there would be more deals coming up: We are going to have several announcements in the next 48 hours. Trump has also threatened an extra 10 percent tariff on countries aligning themselves with the emerging BRICS nations, accusing them of Anti-American policies after they slammed his duties at a summit. But partners are still rushing to avert Trumps tariffs altogether. The European Commission said EU chief Ursula von der Leyen had a good exchange with Trump on trade when the pair spoke Sunday.

Malaysia calls U.S. 25 pct tariff disruptive to business, supply chains
Malaysia calls U.S. 25 pct tariff disruptive to business, supply chains

Malaysia Sun

timean hour ago

  • Malaysia Sun

Malaysia calls U.S. 25 pct tariff disruptive to business, supply chains

Xinhua 08 Jul 2025, 13:15 GMT+10 KUALA LUMPUR, July 8 (Xinhua) -- The imposition of a tariff rate of 25 percent on Malaysian exports to the United States is potentially disruptive to business operations, supply chains, and investment flows that benefit both countries, Malaysia's Investment, Trade and Industry Ministry said on Tuesday. Malaysia is however still committed to negotiations to reach a fair and sustainable outcome for both parties, it said in a statement following a letter by U.S. President Donald Trump addressed to Malaysian King Sultan Ibrahim Sultan Iskandar. "Malaysia views unilateral measures as potentially disruptive to business operations, supply chains, and investment flows that benefit both countries," it said. "Malaysia strongly believes that together, we can find mutually acceptable solutions that safeguard the interests of both our countries and our peoples, while ensuring that bilateral trade and investment remain a positive force for sustainable economic development," it added. The tariff rate is scheduled to be imposed from Aug. 1, 2025.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store